Table 1.
Clinical characteristics of patients enrolled in SWIDINEP at the baseline visit.
| % | Mean | SD | |
|---|---|---|---|
| Age (y) | 63.8 | 10.8 | |
| Sex | |||
| Male | 76.3 | ||
| Female | 23.5 | ||
| Ethnicity | |||
| Caucasian | 83 | ||
| Asian | 1.5 | ||
| African | 8.2 | ||
| Other | 7.4 | ||
| Duration of diabetes (y) | 13.3 | 9.0 | |
| Diagnosis of hypertension | 96 | ||
| Duration of hypertension (y) | 12.3 | 20.9 | |
| BMI (kg/m2) | 31.6 | 5.3 | |
| Smoking History | |||
| Past | 50.4 | ||
| Active | 23.7 | ||
| Never | 25.9 | ||
| Past medical history | |||
| Coronary artery disease | 35.8 | ||
| Stroke | 9.0 | ||
| Peripheral artery disease | 23.0 | ||
| Retinopathy | 35.7 | ||
| Proliferative retinopathy with laser therapy | 37.3 | ||
| Peripheral neuropathy | 54.8 | ||
| Erectile dysfunction | 51.0 | ||
| Lower limb amputation | 4.9 | ||
| Renal function | |||
| eGFR (CKD-EPI) ml/min/1.73 m2 | 60.2 | 26.4 | |
| KDIGO CKD stage | |||
| 1 | 17.1 | ||
| 2 | 29.1 | ||
| 3a | 18.7 | ||
| 3b | 25.4 | ||
| 4 | 9.7 | ||
| eGFR decline (ml/min/1.73 m2/y) | −1.8 | 3.0 | |
| Albumine/creatinine ratio (mg/mmol) | 48.9 | 108.4 | |
| KDIGO CKD stage | |||
| A1 | 22.0 | ||
| A2 | 51.2 | ||
| A3 | 26.8 | ||